XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LC
10 Agosto 2007 - 4:00PM
PR Newswire (US)
VENICE, Fla., Aug. 10 /PRNewswire/ -- XCPT, LLC has entered into a
representation agreement with Lifecore Biomedical, Inc. to market
its products to dentists throughout the world. XCPT's software is a
highly graphic, face-to-face, patient consultation and engagement
method recognizing the importance of visual learning during
treatment planning. With XCPT, the patient is involved in every
step of the dental treatment process as the clinician uses the
patient's own x-rays, CT scans and/or photographs to communicate
treatment options and solutions. "XCPT's software helps patients
decide what is best for them in a trusting, open environment," says
Dr. Steven J. Feldman, CEO of XCPT. "With its use, we're seeing
doctors gain productivity and increased case acceptance by simply
showing the patient what they see." The signing of the agreement
reinforces XCPT's ongoing strategy to be the patient engagement and
communication software of choice for the leading implant
manufacturers, dental schools and dental practices throughout the
country. The agreement with Lifecore marks the third dental implant
company and seventh company overall which has begun to incorporate
XCPT as a practice- building tool throughout their salesforce.
"We're honored and pleased to have forged this agreement with
Lifecore," said Dr. Feldman. "From the time of our first meeting
with Lifecore, we were excited about the prospects of becoming
integrated into their sales and education curriculum. We see the
natural fit between our software's communication capabilities and
Lifecore's ability to market implants worldwide." Speaking on
behalf of Lifecore Dental, a Division of Lifecore Biomedical, John
DeAngelo, Marketing Portfolio Manager, said, "There are four steps
to pre-surgical treatment planning: 1. patient expectations, 2.
prosthetic options, 3. biomechanical principles and 4. the team
approach which involves the surgeon, restoring dentist and the
laboratory. XCPT provides the clinician and their patients a
predictable environment for planning all aspects of the implant
reconstruction. It allows the doctor to make the important
decisions on treatment planning and allows for clear communication
between the treatment team and the patient. Finally, it provides
patient confidence knowing that a team worked together for an
optimal outcome." To reach a Lifecore sales representative in your
area, call 1-800-752- 2663. For more information or to download the
FREE full version 30-day trial, call XCPT at 866.927.9278 or visit
http://www.xcpt.com/ About Lifecore Biomedical Lifecore Biomedical,
Inc. (NASDAQ:LCBM) in business over 40 years, develops,
manufactures and markets biomaterials and medical devices for use
in various surgical markets through two divisions, the Dental
Division and the Hyaluronan Division. The Dental Division conducts
its dental surgery business through direct sales and marketing in
the United States, France, Germany, Italy and Sweden and through
distributors in 49 other countries. The Hyaluronan Division
conducts its business through OEM and contract manufacturing
alliances in the ophthalmic, orthopedic and veterinary surgical
fields. General Corporate Information is available on the internet
at http://www.lifecore.com/ About XCPT, LLC XCPT's Patient
Engagement and Communication software was developed to provide an
innovative communication method for patients and their healthcare
professionals. With its adoption, communication becomes clearer for
dental teams in their relationships with patients, their team
members, and their referral networks. DATASOURCE: XCPT, LLC
CONTACT: Tom Gooch of XCPT, LLC, +1-866-927-9278, Web site:
http://www.xcpt.com/ http://www.lifecore.com/
Copyright
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Lifecore Biomedical (MM) (NASDAQ): 0 recent articles
Más de Lifecore Biomedical (MM) Artículos de Noticias